96 related articles for article (PubMed ID: 15300835)
1. Selective estrogen-receptor modulators (SERMs) in the cyclopentadienylrhenium tricarbonyl series: synthesis and biological behaviour.
Top S; Vessières A; Pigeon P; Rager MN; Huché M; Salomon E; Cabestaing C; Vaissermann J; Jaouen G
Chembiochem; 2004 Aug; 5(8):1104-13. PubMed ID: 15300835
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
3. Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.
Pigeon P; Top S; Vessières A; Huché M; Hillard EA; Salomon E; Jaouen G
J Med Chem; 2005 Apr; 48(8):2814-21. PubMed ID: 15828819
[TBL] [Abstract][Full Text] [Related]
4. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.
Nguyen A; Top S; Pigeon P; Vessières A; Hillard EA; Plamont MA; Huché M; Rigamonti C; Jaouen G
Chemistry; 2009; 15(3):684-96. PubMed ID: 19053086
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen derivatives for delivery of the antitumoral (DACH)Pt group: selective synthesis by McMurry coupling, and biochemical behaviour.
Top S; Kaloun el B; Vessières A; Leclercq G; Laïos I; Ourevitch M; Deuschel C; McGlinchey MJ; Jaouen G
Chembiochem; 2003 Aug; 4(8):754-61. PubMed ID: 12898627
[TBL] [Abstract][Full Text] [Related]
7. Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects.
Vessières A; Top S; Beck W; Hillard E; Jaouen G
Dalton Trans; 2006 Jan; (4):529-41. PubMed ID: 16402138
[TBL] [Abstract][Full Text] [Related]
8. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
9. Synthetic and mechanistic pathways of cis and trans-hydroxytamoxifen drug derivatives reacting with Cp*Rh complexes that involve η1-N, η2-N,O, η1-O, and η6 bonding modes, via a novel N-π rearrangement; relative binding affinities and computer docking studies of cis and trans-η6-Cp*Rh-hydroxytamoxifen complexes at the estrogen, ERα and ERβ receptors, and growth inhibition to breast cancer cells.
Top S; Efremenko I; Rager MN; Vessières A; Yaswen P; Jaouen G; Fish RH
Inorg Chem; 2011 Jan; 50(1):271-84. PubMed ID: 21121684
[TBL] [Abstract][Full Text] [Related]
10. Investigations on the effects of basic side chains on the hormonal profile of (4R,5S)/(4S,5R)-4,5-bis(4-hydroxyphenyl)-2-imidazolines.
von Rauch M; Busch S; Gust R
J Med Chem; 2005 Jan; 48(2):466-74. PubMed ID: 15658860
[TBL] [Abstract][Full Text] [Related]
11. Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds.
Zekri O; Hillard EA; Top S; Vessières A; Pigeon P; Plamont MA; Huché M; Boutamine S; McGlinchey MJ; Müller-Bunz H; Jaouen G
Dalton Trans; 2009 Jun; (22):4318-26. PubMed ID: 19662309
[TBL] [Abstract][Full Text] [Related]
12. New scaffolds for the design of selective estrogen receptor modulators.
Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
[TBL] [Abstract][Full Text] [Related]
13. Rapid synthesis of 4-benzylidene and 4-[bis-(4-methoxyphenyl)-methylene-2-substituted phenyl-benzopyrans as potential selective estrogen receptor modulators (SERMs) using McMurry coupling reaction.
Gupta A; Dwivedy A; Keshri G; Sharma R; Balapure AK; Singh MM; Ray S
Bioorg Med Chem Lett; 2006 Dec; 16(23):6006-12. PubMed ID: 16979337
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of SERMs with potent nongenomic estrogenic activity.
Tobias SC; Qiu J; Kelly MJ; Scanlan TS
ChemMedChem; 2006 May; 1(5):565-71. PubMed ID: 16892393
[TBL] [Abstract][Full Text] [Related]
15. m-Carborane bisphenol structure as a pharmacophore for selective estrogen receptor modulators.
Ogawa T; Ohta K; Yoshimi T; Yamazaki H; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem Lett; 2006 Aug; 16(15):3943-6. PubMed ID: 16735120
[TBL] [Abstract][Full Text] [Related]
16. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
[TBL] [Abstract][Full Text] [Related]
17. Rhenium and technetium tricarbonyl complexes anchored by pyrazole-based tripods: novel lead structures for the design of myocardial imaging agents.
Maria L; Cunha S; Videira M; Gano L; Paulo A; Santos IC; Santos I
Dalton Trans; 2007 Jul; (28):3010-9. PubMed ID: 17622418
[TBL] [Abstract][Full Text] [Related]
18. On-line formation, separation, and estrogen receptor affinity screening of cytochrome P450-derived metabolites of selective estrogen receptor modulators.
van Liempd SM; Kool J; Niessen WM; van Elswijk DE; Irth H; Vermeulen NP
Drug Metab Dispos; 2006 Sep; 34(9):1640-9. PubMed ID: 16790557
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, receptor binding, molecular modeling, and proliferative assays of a series of 17alpha-arylestradiols.
Foy N; Stéphan E; Vessières A; Salomon E; Heldt JM; Huché M; Jaouen G
Chembiochem; 2003 Jun; 4(6):494-503. PubMed ID: 12794859
[TBL] [Abstract][Full Text] [Related]
20. Complexes having the fac-[M(CO)3]+ core (M=Tc, Re) useful in radiopharmaceuticals: X-ray and NMR structural characterization and density functional calculations of species containing two sp3 N donors and one sp3 O donor.
Lipowska M; Cini R; Tamasi G; Xu X; Taylor AT; Marzilli LG
Inorg Chem; 2004 Nov; 43(24):7774-83. PubMed ID: 15554642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
